Imiquimod use in the treatment of lentigo maligna - 07/08/11
Abstract |
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Jacqueline M. Junkins-Hopkins, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
Le texte complet de cet article est disponible en PDF. The statements and opinions expressed in this commentary are those of the Editor-in-Chief of Dialogues in Dermatology. |
|
Funding sources: None. |
|
Conflicts of interest: Dr Chapman is supported by 3M with grants and is a consultant with Graceway. Dr Brown is a speaker for and received honoraria from Dermik, Galderma, Novartis, and Stiefel. Dr Junkins-Hopkins declared no conflicts of interest. |
Vol 61 - N° 5
P. 865-867 - novembre 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?